NNNN (Anbio Biotechnology Class A Ordinary Shares) Stock Analysis - Hedge Fund Holdings

Anbio Biotechnology Class A Ordinary Shares (NNNN) is a publicly traded Healthcare sector company. As of May 21, 2026, NNNN trades at $31.00 with a market cap of $1.24B and a P/E ratio of 0.00. NNNN moved +2.57% today. Year to date, NNNN is -6.90%; over the trailing twelve months it is +298.00%. Its 52-week range spans $5.18 to $55.65. Rallies surfaces NNNN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns NNNN stock?

Rallies tracks hedge fund and 13F ownership for NNNN, including fund holders, share counts, and position changes when data is available.

NNNN Key Metrics

Key financial metrics for NNNN
MetricValue
Price$31.00
Market Cap$1.24B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$55.65
52-Week Low$5.18
Volume110
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest NNNN News

NNNN Analyst Consensus

NNNN analyst coverage data. Average price target: $0.00.

Common questions about NNNN

Who owns NNNN stock?
Rallies tracks hedge fund and 13F ownership for NNNN, including fund holders, share counts, and position changes when data is available.
Does Rallies show 13F holders for NNNN?
Yes. Rallies tracks hedge fund and 13F ownership data for NNNN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is NNNN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NNNN. It does not provide personalized investment advice.
NNNN

NNNN